A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-cell Therapy

著者： Annenberg Center for Health Sciences
無料で聴く

  • サマリー

  • In this activity, Jeremy Abramson, MD, highlights the significant disease burden of B-cell lymphomas, as well as the latest advances in therapeutics, and practical strategies for integrating novel therapies into practice through patient selection and supportive care management.
    Annenberg Center for Health Sciences
    続きを読む 一部表示

あらすじ・解説

In this activity, Jeremy Abramson, MD, highlights the significant disease burden of B-cell lymphomas, as well as the latest advances in therapeutics, and practical strategies for integrating novel therapies into practice through patient selection and supportive care management.
Annenberg Center for Health Sciences
衛生・健康的な生活 身体的病い・疾患
続きを読む 一部表示
エピソード
  • Principles of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma: Patient Selection Strategies

    Principles of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Large B-Cell Lymphoma: Patient Selection Strategies
    2022/06/09

    Large B-cell lymphomas (LBCLs) are one of the most common subtypes of non-Hodgkin lymphomas and while 1st-line standard of care has remained unchanged, the treatment paradigm has undergone a shift in recent years due to the development of novel therapeutic agents. These novel therapies include monoclonal antibody (mAb) therapies, mAb-conjugates, and chimeric antigen receptor (CAR)-T cell therapies.
    続きを読む 一部表示
    8 分
  • Treatment of Large B-Cell Lymphoma: MOA and Clinical Efficacy Data of Novel Therapies

    Treatment of Large B-Cell Lymphoma: MOA and Clinical Efficacy Data of Novel Therapies
    2022/06/09

    Treatment of Large B-Cell Lymphoma: MOA and Clinical Efficacy Data of Novel Therapies
    続きを読む 一部表示
    37 分
  • Disease Burden and Overview of Large B-Cell Lymphomas

    Disease Burden and Overview of Large B-Cell Lymphomas
    2022/06/09

    B-cell lymphomas consist of a heterogenous group of lymphoproliferative neoplasms originating from B-lymphocytes.  
    続きを読む 一部表示
    4 分

A Critical Update on Relapsed/Refractory Diffuse Large B-Cell Lymphoma and CAR T-cell Therapyに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。